EXAS250117C82500
- 0.15
- 0.000.00%
Exact Sciences Newsroom
Citi Says 'Buy' These Stocks in '25; SA Quant Ratings Says Maybe Not
Bernstein Maintains Exact Sciences(EXAS.US) With Buy Rating, Maintains Target Price $70
Analysts Offer Insights on Healthcare Companies: Exact Sciences (EXAS), Denali Therapeutics (DNLI) and Inspire Medical Systems (INSP)
Evercore Maintains Exact Sciences(EXAS.US) With Buy Rating, Cuts Target Price to $70
Exact Sciences Price Target Raised to $70 From $60 at Evercore ISI
Exact Sciences to Participate in J.P. Morgan Healthcare Conference
(EXAS) - Analyzing Exact Sciences's Short Interest
Would Exact Sciences (NASDAQ:EXAS) Be Better Off With Less Debt?
Analysts Are Bullish on These Healthcare Stocks: Exact Sciences (EXAS), Neurocrine (NBIX)
Exact Sciences Is Maintained at Buy by B of A Securities
Exact Sciences Analyst Ratings
BofA Securities Maintains Exact Sciences(EXAS.US) With Buy Rating, Cuts Target Price to $72
10 BofA U.S. Options Overwriting Ideas
Express News | Exact Sciences Corp : Leerink Partners Raises Target Price to $95 From $70
TD Cowen Maintains Exact Sciences(EXAS.US) With Buy Rating, Maintains Target Price $86
Exact Sciences (EXAS) Gets a Buy From TD Cowen
AAPA Awarded Grant From Exact Sciences to Improve Colorectal Cancer Screening Rates
Exact Sciences Corporation's (NASDAQ:EXAS) Shares Lagging The Industry But So Is The Business
Exact Sciences Corporation (EXAS) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript)
Exact Sciences Corporation (EXAS) Citi's 2024 Global Healthcare Conference (Transcript)